Brown Brothers Harriman & Co’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Brown Brothers Harriman & Co’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-56	Closed	-$3K	–	1551
2022 Q3	$3K	Sell	56 -31	-36%	-$2K	﹤0.01%	1404
2022 Q2	$6K	Sell	87 -4	-4%	-$292	﹤0.01%	1130
2022 Q1	$7K	Hold	91	–	–	﹤0.01%	1093
2021 Q4	$9	Hold	91	–	–	﹤0.01%	944
2021 Q3	$8	Hold	91	–	–	﹤0.01%	946
2021 Q2	$8	Hold	91	–	–	﹤0.01%	930
2021 Q1	$7	Hold	91	–	–	﹤0.01%	928
2020 Q4	$6K	Buy	+91	New	+$5.67K	﹤0.01%	929
2018 Q3	–	Sell	-137	Closed	-$6K	–	904
2018 Q2	$6K	Buy	+137	New	+$5.67K	﹤0.01%	727

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brown Brothers Harriman & Co's SYNH Position: Q4 2022 in Review

Brown Brothers Harriman & Co sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 56 shares — an estimated $3K sold.

Brown Brothers Harriman & Co first reported a position in SYNH in Q2 2018 and held it in 9 quarters. The position peaked at $7K in Q1 2022. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

Brown Brothers Harriman & Co reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Brown Brothers Harriman & Co sold 56 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $3K.
Brown Brothers Harriman & Co first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2018 and held it in 9 quarters.
Brown Brothers Harriman & Co's Syneos Health, Inc. Class A Common Stock position peaked at $7K in Q1 2022.
307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2022, filed 9 Feb 2023.